Search results
Jump to navigation
Jump to search
Page title matches
- A '''monoclonal antibody''' is an immune substance "produced by clones of cells such as those isolat * [[Human monoclonal antibody]]. INN names end in -umab. Example is [[olaratumab]].2 KB (244 words) - 09:00, 26 April 2014
- 198 bytes (33 words) - 00:55, 5 September 2009
- ...anized. If only the constant region is modified they are called [[Chimeric monoclonal antibody|chimeric]]." <ref>{{MeSH}}</ref> * [[Humanized monoclonal antibody]]. INN names end in -zumab787 bytes (103 words) - 08:56, 26 April 2014
- 411 bytes (60 words) - 08:46, 26 April 2014
- Auto-populated based on [[Special:WhatLinksHere/Monoclonal antibody]]. Needs checking by a human.640 bytes (83 words) - 18:38, 11 January 2010
Page text matches
- ...anized. If only the constant region is modified they are called [[Chimeric monoclonal antibody|chimeric]]." <ref>{{MeSH}}</ref> * [[Humanized monoclonal antibody]]. INN names end in -zumab787 bytes (103 words) - 08:56, 26 April 2014
- A '''monoclonal antibody''' is an immune substance "produced by clones of cells such as those isolat * [[Human monoclonal antibody]]. INN names end in -umab. Example is [[olaratumab]].2 KB (244 words) - 09:00, 26 April 2014
- ...ounds (e.g., aurothioglucose), [[antimalarial]]s, [[penicillamine]], and [[monoclonal antibody|monoclonal antibodies]] against [[tumor necrosis factor-alpha]] and other i422 bytes (46 words) - 19:00, 18 September 2010
- A [[monoclonal antibody]] used as an [[antineoplastic agent]]97 bytes (11 words) - 12:24, 17 July 2010
- A [[monoclonal antibody]] useful in treatment of [[HER2]]-positive metastatic [[breast cancer]]131 bytes (15 words) - 07:56, 5 February 2009
- <noinclude>{{Subpages}}</noinclude>An antineoplastic agent that uses a [[monoclonal antibody]] to deliver radioisotopes to cancer cells135 bytes (17 words) - 00:53, 1 November 2010
- Antibodies include [[monoclonal antibody|monoclonal antibodies]].412 bytes (53 words) - 08:33, 26 April 2014
- A [[antineoplastic agent]], of the [[monoclonal antibody]] class, directed against the CDw52 antigen expressed by [[lymphocyte]]s165 bytes (20 words) - 09:14, 5 February 2009
- Chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cell204 bytes (30 words) - 10:52, 8 September 2009
- {{r|Monoclonal antibody}}381 bytes (44 words) - 10:34, 18 October 2008
- {{r|Monoclonal antibody}}196 bytes (22 words) - 16:49, 1 August 2010
- [[Cetuximab]] (IMC-C225) is a recombinant, human/mouse chimeric [[monoclonal antibody]] that binds to EGFR and may treat head and neck cancers, [[colorectal canc ...&id=19339720 | doi=10.1056/NEJMoa0805019 }} </ref> Panitumumab is also a [[monoclonal antibody]] that binds to EGFR and may treat [[colorectal cancer]].1 KB (208 words) - 07:56, 1 May 2010
- ...''trastuzumab''' (pronounced tras too' zoo mab), '''Herceptin''' ®, is a [[monoclonal antibody]] against the [[ErbB-2 receptor]] (HER2) that lengthens remission time in m707 bytes (88 words) - 11:35, 23 March 2010
- {{r|Catumaxomab}} Is a monoclonal antibody against CD3 (Entrez protein)and EpCAM (Entrez protein). "Extracorporeal PBM {{r|Bevacizumab}}is an "anti-VEGF (Entrez protein) monoclonal antibody consisting of humanized murine antibody with antigen-binding, complementary4 KB (467 words) - 00:17, 6 February 2009
- {{r|Anti-TNF monoclonal antibody||**}}1 KB (149 words) - 03:19, 28 December 2010
- Auto-populated based on [[Special:WhatLinksHere/Monoclonal antibody]]. Needs checking by a human.640 bytes (83 words) - 18:38, 11 January 2010
- [[Monoclonal antibody|monoclonal antibodies]] targeting [[tumor necrosis factor]] are the most re2 KB (190 words) - 13:54, 25 June 2010
- The [[monoclonal antibody]] [[palivizumab]], three to five monthly [[intramuscular injection]]s, can932 bytes (122 words) - 06:13, 23 August 2010
- {{r|Monoclonal antibody}}958 bytes (113 words) - 15:14, 18 January 2010
- {{r|Monoclonal antibody}}1 KB (141 words) - 22:00, 30 July 2010
- * [[Cetuximab]] (IMC-C225) is a recombinant, human/mouse chimeric [[monoclonal antibody]] that binds to [[epidermal growth factor receptor]] (ErbB1, EGFR) and may * [[Catumaxomab]]. Is a monoclonal antibody against CD3 ([http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein&term=NM_010 KB (1,356 words) - 06:07, 5 April 2024
- {{r|Monoclonal antibody}}2 KB (219 words) - 21:43, 11 January 2010
- [[Antitoxin]]s, drugs using [[monoclonal antibody|monoclonal antibodies]], etc., which directly attack or neutralize the path ...directly counteract the effects of the pathogen, as do [[antitoxin]]s or [[monoclonal antibody|monoclonal antibodies]] that kill organisms, passively add immune defensive7 KB (1,004 words) - 10:12, 30 May 2009
- }}</ref> [[monoclonal antibody]] consisting of humanized [[murine]] antibody with antigen-binding, complem3 KB (376 words) - 14:53, 17 July 2010
- The leading edge of approved treatment, however, are specific [[monoclonal antibody|monoclonal antibodies]].4 KB (541 words) - 14:37, 31 July 2010
- [[Trastuzumab]] is a [[monoclonal antibody]] against the ErbB-2 receptor that lengthens remission time in metastatic [2 KB (308 words) - 06:03, 16 July 2010
- * [[Infliximab]] (Remicade) (pronounced in flix' i mab) is a chimeric monoclonal antibody that blocks the action of TNF-alpha by binding to it.<ref>{{CZMed|Inflixima8 KB (1,138 words) - 02:03, 4 November 2010
- * [[Adalimumab]] is a [[monoclonal antibody]].2 KB (306 words) - 17:09, 26 May 2023
- ...opurine]] and [[azathioprine]], as well as [[methotrexate]]. Recently, a [[monoclonal antibody]] against [[tumor necrosis factor-alpha]], [[infliximab]], has come into us4 KB (547 words) - 16:34, 2 August 2010
- [[Rituximab]], a [[monoclonal antibody]], was found to be safe by a [[systematic review]] of 21 studies, although3 KB (477 words) - 12:55, 8 September 2020
- 3 KB (445 words) - 15:57, 28 June 2010
- ...s of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]] [[abciximab]] and the small-molecule agents [[tirofiban]] and [[eptifiba4 KB (543 words) - 01:43, 8 May 2013
- ...he person's blood. Any p24 protein in the person's blood will stick to the monoclonal antibody and enzyme-linked antibody to the monoclonal antibodies to p24 causes a col26 KB (3,990 words) - 13:22, 2 February 2023
- 5 KB (667 words) - 11:08, 30 September 2011
- ...d for [[non-Hodgkin’s lymphom]]a. <sup>90</sup>Y-Ibritumomab Tiuxetan, a [[monoclonal antibody]], is currently unavailable in generic form due to its patented brand name, ...ation with radioactive <sup>90</sup>[[Yttrium]]. Ibritumomab Tiuxetan, the monoclonal antibody, is therefore coupled with a radioactively [[cytotoxic]] agent capable of d11 KB (1,563 words) - 03:38, 7 October 2013
- ...e development and control of the [[immune system]] and the production of [[monoclonal antibody|monoclonal antibodies]]21 KB (2,676 words) - 09:02, 1 March 2024
- *[[Monoclonal antibody/Definition]]15 KB (1,521 words) - 09:02, 2 March 2024
- 38 KB (5,208 words) - 09:02, 1 March 2024
- ...ontrolled trial]], the [[relative risk ratio]] of adjunct treatment with [[monoclonal antibody|monoclonal antibodies]] against C. difficile toxins, as compared to [[place46 KB (6,252 words) - 17:10, 31 October 2013
- ...fit for some patients but generally do not slow disease progression. Newer monoclonal antibody treatments against beta-amyloid protein, for example, the drug Leqembi, hav16 KB (2,171 words) - 08:34, 6 March 2024
- ...ions measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus ''J Clin Endocrin31 KB (4,537 words) - 09:57, 18 February 2011
- The [[monoclonal antibody]] against [[interleukin]]-1 beta, [[canakinumab]], may help according to a24 KB (3,312 words) - 17:35, 10 February 2024
- ...ng allows plants to be modified to express proteins such as a therapeutic monoclonal antibody used in the treatment of arthritis, vaccine proteins, or for treatment of d23 KB (3,331 words) - 21:51, 3 March 2010
- Cetuximab, an I<sub>g</sub>G1 chimeric monoclonal antibody against epidermal growth factor receptor, may help according to a [[randomi31 KB (4,194 words) - 13:28, 10 February 2023
- ...refractory cases. TNF-a is a cachexin or cachectin. Its inhibitors, all [[monoclonal antibody|monoclonal antibodies]]; they are immunosuppressive with attendant risks. T48 KB (6,593 words) - 11:52, 2 February 2023
- ...m, and cerebellum regions. Using an immunohistochemical analysis for OX-42 monoclonal antibody, they found a marked reduction of microglial activation in ribavirin-treate28 KB (4,083 words) - 03:50, 14 February 2010
- ...e patients may be candidates for the drug [[trastuzumab]] (Herceptin), a [[monoclonal antibody]] that targets this protein. [[Trastuzumab]] may be used both in the posts ...presses an over-abundance of the [[erbB-2 receptor]] (HER2, HER2/neu), a [[monoclonal antibody]] known as [[trastuzumab]] (Herceptin ®) is used to block the activity of101 KB (14,716 words) - 09:04, 5 April 2024
- Denosumab is a humanized monoclonal antibody that inhibits osteoclasts.<ref name="pmid16495394">{{cite journal |author=M49 KB (6,739 words) - 13:28, 10 February 2023